LivaNova (LIVN) EBIT Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | -14.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.70% |
| Dec 31, 2025 | 15.01% |
| Sep 30, 2025 | 51.64% |
| Jun 30, 2025 | 34.90% |
| Mar 31, 2025 | 199.26% |
| Dec 31, 2024 | 142.07% |
| Sep 30, 2024 | 698.97% |
| Jun 30, 2024 | 131.16% |
| Mar 31, 2024 | 793.68% |
| Dec 31, 2023 | -730.30% |
| Sep 30, 2023 | 103.38% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -124.64% |
| Dec 31, 2022 | -43.61% |
| Sep 30, 2022 | -903.64% |
| Jun 30, 2022 | 187.57% |
| Mar 31, 2022 | 266.81% |
| Dec 31, 2021 | 109.94% |
| Sep 30, 2021 | 317.45% |
| Jun 30, 2021 | -116.58% |
| Mar 31, 2021 | -880.72% |
| Dec 31, 2020 | -72.96% |
| Sep 30, 2020 | -129.32% |
| Jun 30, 2020 | 43.96% |
| Mar 31, 2020 | 97.20% |
| Dec 31, 2019 | 47.92% |
| Sep 30, 2019 | 547.47% |
| Jun 30, 2019 | -238.27% |
| Mar 31, 2019 | -265.83% |
| Dec 31, 2018 | -1,559.39% |
| Sep 30, 2018 | -119.18% |
| Jun 30, 2018 | -22.21% |
| Mar 31, 2018 | -36.55% |
| Dec 31, 2017 | 227.35% |
| Sep 30, 2017 | -1.16% |
| Jun 30, 2017 | 11.02% |
| Mar 31, 2017 | 317.62% |
| Oct 18, 2015 | -200.34% |
| Apr 24, 2015 | -74.85% |